Figure 4. Signature evaluation in relationship to TME signals and activation of immune checkpoints. (A) Differences of 22 different types of tumor-infiltrating immune cells between low- and high-risk groups evaluated by the CIBERSORT algorithm. (B) ssGSEA scores evaluating differences in 13 immune-related functions between high-risk and low-risk groups. (C) The expression of immune checkpoints in low- and high-risk groups.
